December 6th, 2011 by DrWes in Opinion
3 Comments »
Several days ago, the world’s leading cholesterol-lowering “statin” drug, Lipitor, went generic. Doctors are bearing the brunt of the conversion with little information about what the new drug will cost for their patients.
This, of course, is the plan.
Even the Wall Street Journal which has an excellent “user’s guide” to making the switch from name-brand to generic Lipitor offers little help as it mentions “co-pays” rather than actual drug cost:
How much cheaper will generic Lipitor be?
Insurance copayments should drop considerably, if patients are getting Lipitor or atorvastatin on the generic tier of their health plans. Currently, Lipitor has been on a higher, branded tier for prescription drugs. Copays for branded drugs average either $29 or $49 depending on the tier, according to Kaiser Family Foundation. Copays for generics average $10.
In addition, Ranbaxy Laboratories Ltd, one of the generic manufacturers of generic Lipitor, won concessions to maintain elevated prices for 180 days from the government (a la our own Food and Drug Administration while the Federal Trade Commission stands idly by complaining how consumers are gouged with this arrangement) to assure prices stay high a bit longer.
But if we forget the insurers and copays, how much will the generic drug actually cost consumers? Read more »
August 7th, 2011 by Happy Hospitalist in Opinion, Research
No Comments »
I’ve been telling my smoking patients for years that nothing I do for them is going to make an ounce of difference until they quit smoking for good. And the Italians are out to prove me right. The American Journal of Cardiology reported July 11th, 2011 on the Effect of Smoking Relapse On Outcome After Acute Coronary Syndrome.
In a study of just under 1,300 patients, Reuters reports that just over 1/2 the patients started smoking within 20 days of hospital discharge, despite in-hospital smoking cessation consultation for all patients. Researchers also found that resuming smoking increased death 3-fold compared with those that did not relapse and quitting smoking had a similar lifesaving effect as taking cholesterol and blood pressure medications. And I’m sure these folks all landed themselves back into the hospitals for a very expensive dying process.
That’s why billing the patient or their insurance for smoking cessation (CPT® 99406 and 99407) is so important. And that’s why I give many of my smoking patients my smoking lecture. You know how much Medicare pays for a ten minute consultation to help cardiac patients quit smoking right now? Read more »
*This blog post was originally published at The Happy Hospitalist*
July 19th, 2011 by RyanDuBosar in Health Policy, Research
No Comments »
Generic medications appear to be far more cost-effective than previously reported, concluded a team of Harvard professors. But, physicians and patients aren’t adopting them wholeheartedly.
Patents of 20 drugs with annual sales of more than $1 billion expired or will do so between 2010 and 2013, including Lipitor and Plavix, the highest- and second-highest revenue producing drugs in the U.S. While highly effective generics provide low-cost options for chronic disease management, they are not always factored into cost analyses, and are sometimes viewed with concerns about their safety and efficacy.
The Harvard team revisited a 2008 study that used brand-name medication costs in an analysis of the cost-effectiveness of strategies to prevent adverse outcomes associated with cardiovascular disease and diabetes. The study found that up to 244 million quality-adjusted life-years could be gained over 30 years with appropriate preventive care. But, the study authors wrote, that “most prevention activities are expensive when considering direct medical costs.”
The Harvard team recalculated figures from the 2008 research, Read more »
*This blog post was originally published at ACP Internist*
June 8th, 2011 by John Mandrola, M.D. in Health Tips
No Comments »
When cyclists find out that I am a heart doctor, they most frequently ask about cholesterol numbers.
“…My cholesterol is this…What do you think?”
“…My doctor wants me to take a statin…But I read that these drugs might lower my functional threshold power 2.014 watts/40km.”
All this focus on numbers saddens me. Remember, I am a forest guy, not a tree guy. What’s more, as a doctor that revels in the adrenaline rush of ablating rogue circuits with technology that would impress even a twenty-something, I find questions about biochemistry dreary–like eating quinoa.
I wish folks would ask me about how to terminate AF with a catheter, or how an (evidenced-based) ICD saved a mom’s life, or perhaps even this: “Do you do heart surgery?”
But more often than not people want to know about cholesterol.
Okay. It just so happens that this week brought some very interesting news concerning the treatment of abnormal cholesterol lab values. News that big-picture docs have to like. Read more »
*This blog post was originally published at Dr John M*
June 6th, 2011 by AndrewSchorr in True Stories
1 Comment »
You may recall, I have a beef with Madison Avenue ad agencies that keep serving up the same New York actors in television commercials for different illnesses. I take it personally. The woman with cancer also has asthma. The man with arthritis also has erectile dysfunction. I feel bad for them!
Last night the quest by an actor to find work got ridiculous for me as my wife, Esther, and I were watching one of our favorite shows, “Criminal Minds,” on CBS. It was a particularly violent episode where a Bonnie and Clyde-type couple shot their way across Montana and proved to be the sickest of cold blooded killers. As the story develops, both the young man and the young woman were abused as children and their plan becomes to mete out retribution to the parents who ruined their lives.
Late in the show the young woman confronts a gray haired man in his 50’s behind the counter at his service station-convenience store. It was her father. She points a gun at him while he pleads for his life. I turned to Esther and said “I know that man! Where do I know him from?” Esther didn’t know and I couldn’t remember. Back on the screen things go from bad to worse, and while the young woman hesitates, her boyfriend sends the father to the hereafter. It was so sad. Where do I know that guy from???? Read more »
*This blog post was originally published at Andrew's Blog*
